PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage

Area of Science:

• Molecular biology
• Cancer research
• DNA repair mechanisms

Background:

• PTEN's cytoplasmic role in antagonizing the PI3K-AKT pathway is established.
• The nuclear functions and regulation of PTEN, particularly in DNA damage response, are not well understood.

Purpose of the Study:

• To elucidate the molecular mechanisms governing PTEN's function within the nucleus during DNA double-strand break (DSB) repair.
• To investigate the role of PTEN methylation in DNA damage response and its potential as a therapeutic target.

Main Methods:

• Utilized cell culture and in vivo xenograft models to study PTEN regulation.
• Employed techniques to analyze protein-protein interactions, phosphorylation, and methylation.
• Investigated the impact of inhibiting PTEN methylation or NSD2 on DNA repair and cancer cell sensitivity to treatments.

Main Results:

• DNA DSBs induce PTEN interaction with MDC1 through ATM-dependent phosphorylation.
• DNA DSBs enhance NSD2-mediated dimethylation of PTEN, facilitating its recruitment to damage sites via 53BP1.
• Inhibition of PTEN methylation sensitizes cancer cells to combinatorial PI3K inhibitor and DNA-damaging agent treatment.

Conclusions:

• A novel mechanism for PTEN nuclear regulation in DSB repair involving methylation and protein phosphatase activity is described.
• NSD2-mediated PTEN dimethylation, recognized by 53BP1, is crucial for efficient DSB repair.
• Targeting PTEN methylation presents a potential strategy to enhance cancer therapy efficacy.